[Promotion of Personalized Medicine by Appropriate Utilization of Tumor Markers and Companion Diagnostics].

Szczegóły
Abstrakt

Tytuł:: [Promotion of Personalized Medicine by Appropriate Utilization of Tumor Markers and Companion Diagnostics].
Autorzy:: Tohda S
Źródło:: Rinsho byori. The Japanese journal of clinical pathology [Rinsho Byori] 2017 Mar; Vol. 65 (3), pp. 314-316.
Typ publikacji:: Journal Article
Język:: Japanese
Imprint Name(s):: Publication: Tokyo : Nihon Rinsho Byori Gakkai
Original Publication: Tokyo.
MeSH Terms:: Biomarkers, Tumor*
Molecular Targeted Therapy*
Precision Medicine*
Humans
Substance Nomenclature:: 0 (Biomarkers, Tumor)
Entry Date(s):: Date Created: 20190226 Date Completed: 20190307 Latest Revision: 20190307
Update Code:: 20240104
PMID:: 30802016
: Czasopismo naukowe

Standardization based on clinical guidelines and personalization by molecular-targeted therapy have been introduced into the field of cancer treatment. To select patients appropriate for molecular-targeted drugs, various companion diagnostics have been developed. To catch up with revision of the clinical guidelines and progress of companion diagnostics, the effective utilization of "Guidelines for clinical examinations JSLM2015" is desirable. [Review].

Informacja